10 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... long-acting β2-agonist; ICS ... #LABA #ICS #Guidelines
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Asthma (GINA) treatment ... ICS: inhaled corticosteroids ... receptor antagonists; LABA ... long-acting β2-agonists; OCS ... #Algorithm #Guidelines
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... of expiration; ICS ... #Algorithm #Management ... #Pulmonary #LABA ... #ICS #Pharmacology
LABA/ICS Combination Inhalers
Long-Acting Beta2 Agonists (LABA) + Inhaled Corticosteroid (ICS) - Commonly used in Asthma 
Advair
LABA/ICS Combination ... posts for the COPD treatment ... algorithm). ... are the normal dosing ... Naming #Names #Pharmacology
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
first-line therapies is ... overlap; ICS = ... corticosteroids; LABA ... #Differences #Algorithm ... #Treatment
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
/LABA/ICS) - ... < 100 Dosing: ... recommendations for the treatment ... low, adding an ICS ... #Indications #Pharmacology
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
resynchronization therapy; DM, diabetes ... hypertension; ICD ... ventricular hypertrophy; MCS ... CHF #Congestive #HeartFailure ... Stages #ACCAHA #Algorithm
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
dependent DM ACS ... algorithm to determine ... Diabetes regimen ... • <12mo since ACS ... Determine if any labs
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
INDICATION: Treatment ... oral suspension DOSING ... with CKD, HF, or diabetes ... ACE inhibitors, ... #Hyperkalemia #Pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
lab markers such ... then be excreted using ... #differential #algorithm ... table #foamed #heartfailure ... #clinical #pharmacology